Zoetis Inc. $ZTS Shares Bought by Ashton Thomas Private Wealth LLC

Ashton Thomas Private Wealth LLC grew its stake in shares of Zoetis Inc. (NYSE:ZTS) by 6.5% in the 2nd quarter, Holdings Channel.com reports. The fund owned 27,544 shares of the company’s stock after purchasing an additional 1,674 shares during the quarter. Ashton Thomas Private Wealth LLC’s holdings in Zoetis were worth $4,295,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Sound Income Strategies LLC boosted its holdings in shares of Zoetis by 54.3% in the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after buying an additional 152 shares during the period. Canoe Financial LP boosted its holdings in shares of Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock valued at $2,085,000 after buying an additional 11,975 shares during the period. Strs Ohio acquired a new position in shares of Zoetis in the 1st quarter valued at about $22,891,000. Tandem Investment Advisors Inc. boosted its holdings in shares of Zoetis by 100.3% in the 1st quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company’s stock valued at $65,140,000 after buying an additional 198,089 shares during the period. Finally, Soros Capital Management LLC boosted its holdings in shares of Zoetis by 32.0% in the 1st quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after buying an additional 4,230 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ZTS shares. UBS Group decreased their price target on shares of Zoetis from $165.00 to $158.00 and set a “neutral” rating for the company in a report on Monday, October 20th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Finally, Argus reissued a “buy” rating and set a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. Four equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Zoetis has a consensus rating of “Hold” and an average price target of $195.00.

Zoetis Trading Up 1.1%

Zoetis stock opened at $147.57 on Tuesday. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The firm has a 50-day moving average price of $148.08 and a two-hundred day moving average price of $153.52. The firm has a market capitalization of $65.40 billion, a price-to-earnings ratio of 25.40, a PEG ratio of 2.35 and a beta of 0.90. Zoetis Inc. has a 52-week low of $139.34 and a 52-week high of $184.40.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s dividend payout ratio is currently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.